Hougen Elizabeth L's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Mar 18, 2026
- Accession no.
- 0000874015-26-000146
- Filed
- Mar 18, 2026
- Trade date
- Mar 16-17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $16.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hougen Elizabeth LCIK 0001074773 | Officer (EVP, Finance & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +60,299 | $60.89 | +$3,671,606.11 | 193,180 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +61,041 | $56.78 | +$3,465,907.98 | 254,221 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +33,118 | $32.60 | +$1,079,646.8 | 287,339 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +20,541 | $37.58 | +$771,930.78 | 307,880 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −205,608 | $72.38 | −$14,881,907.04 | 102,272 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −9,440 | $72.77 | −$686,948.8 | 92,832 | Direct | |
| Mar 17, 2026 | Common Stock | SSaleDisposed | −10,172 | $73.21 | −$744,692.12 | 82,660 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −33,118 | $0.00 | $0 | 0 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −20,541 | $0.00 | $0 | 5,405 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −61,041 | $0.00 | $0 | 0 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −60,299 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.